Equities

Adherium Ltd

Adherium Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.018
  • Today's Change0.001 / 5.88%
  • Shares traded2.07m
  • 1 Year change-58.09%
  • Beta3.1303
Data delayed at least 20 minutes, as of May 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.

  • Revenue in AUD (TTM)4.05m
  • Net income in AUD-8.71m
  • Incorporated2015
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Allegra Medical Technologies Ltd-1.07m-2.69m3.47m4.00k---------0.0245-0.0395-0.0098-0.0135-0.3718-------93.15-21.72-2,036.46-29.07--58.84---49.44---6.88----1,200.00-87.74-3.50---49.57--
Uscom Ltd3.39m-2.10m5.63m11.00--2.04--1.66-0.0119-0.01190.01920.01130.53880.66786.87---33.36-28.64-48.04-33.7184.2085.58-61.91-49.931.31-21.480.5863--3.63-0.8707-31.36---8.50--
Visioneering Technologies Inc12.98m-5.17m6.57m----0.7289--0.5060-0.1527-0.15270.38030.16461.041.9510.25---41.20-76.38-50.73-97.7054.9044.90-39.80-98.702.85--0.00--19.0121.3641.05------
Inhalerx Ltd1.21m-1.44m7.59m----11.41--6.29-0.0076-0.00760.00640.00350.629--2.89---75.27-80.34-112.38-99.88-----119.67-500.13---175.270.4571--2,226.0922.7925.10------
Bluechiip Ltd720.41k-5.85m7.71m7.00--4.96--10.70-0.0068-0.00680.00080.00140.14810.12070.7382---120.26-50.46-305.73-61.9864.1760.32-812.09-605.140.265-58.500.2676---1.3210.26-64.78--9.49--
Control Bionics Ltd6.43m-4.82m8.19m----0.9026--1.27-0.0471-0.04710.06260.05320.64431.983.75---48.27-35.68-54.75-38.8176.5166.18-74.92-96.312.89-293.800.0101--25.1545.937.70--99.91--
Osteopore Ltd2.22m-4.87m8.61m----10.55--3.88-0.0901-0.09010.04150.00750.63862.083.23---140.31---387.70--73.78---219.71--0.6869-448.580.7165--31.02---16.13------
Adherium Ltd4.05m-8.71m12.41m----1.28--3.06-0.0252-0.02520.01170.01320.35840.98752.83---77.05-119.77-98.58-166.8468.5144.60-214.98-408.702.16--0.0045--50.87-3.991.85---39.21--
Highcom Ltd55.97m-13.45m15.92m----0.5514--0.2844-0.1316-0.13160.55050.28111.291.9417.40---30.933.75-37.017.3322.2633.50-24.033.220.8596--0.0844--52.5838.886.18112.9341.20--
Cardiex Ltd12.90m-9.41m16.18m26.00--364.01--1.25-0.0611-0.06110.07480.00020.83110.465524.75---60.59-72.35-238.37-127.5392.9081.46-72.90-182.600.847-3.380.9972--8.053.86-59.93--74.79--
Atomo Diagnostics Ltd3.11m-7.37m19.82m----1.45--6.38-0.0124-0.01240.00520.02140.17610.96342.18---41.73-31.79-44.36-35.8841.9742.26-237.01-130.747.06--0.0124---79.3854.68-74.49---8.99--
Cleanspace Holdings Ltd13.66m-5.44m23.97m----1.20--1.75-0.0706-0.07060.17710.25840.45231.104.85---18.02-2.29-21.72-2.9070.4074.09-39.83-2.763.72--0.1562---9.479.3827.92---50.70--
Data as of May 20 2024. Currency figures normalised to Adherium Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

9.16%Per cent of shares held by top holders
HolderShares% Held
FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 202431.13m9.16%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.